(Q50312153)
Statements
Commentary: considerations on the pharmacotherapy of attention deficits and hyperactivity in children with autism and other pervasive developmental disorders. (English)
1 reference
Nicolson R
1 reference
1 October 2000
1 reference
30
1 reference
5
1 reference
461-462
1 reference